Back
Editas Medicine Stock Price Chart

The Tariff-Proof Asset in Your Pocket
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
13
EDIT
Editas Medicine
Last Price:
$1.41
Seasonality Move:
-10.13%
7 Day Trial
ALL ACCESS PASS
$
7

Economy going through a "period of transition" - Your portfolio doesn't have to
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EDIT is experiencing buying pressure, which is a positive indicator for future bullish movement.
Editas Medicine Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.64 | Sell |
20-day SMA: | 1.75 | Sell |
50-day SMA: | 1.48 | Sell |
200-day SMA: | 3.23 | Sell |
8-day EMA: | 1.59 | Sell |
20-day EMA: | 1.64 | Sell |
50-day EMA: | 1.68 | Sell |
200-day EMA: | 3.23 | Sell |
Editas Medicine Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0 | Sell |
Relative Strength Index (14 RSI): | 45.59 | Sell |
Chaikin Money Flow: | 335257 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
Editas Medicine Technical Analysis
Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
03 | 04 | 05 | 06 | 07 | 11 | 12 | 13 | 14 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Editas Medicine Stock
Is Editas Medicine Stock a Buy?
-
Editas Medicine share price is 1.46 while EDIT 8-day simple moving average is 1.64, which is a Sell signal.
-
The stock price of EDIT is 1.46 while Editas Medicine 20-day SMA is 1.75, which makes it a Sell.
-
Editas Medicine 50-day simple moving average is 1.48 while EDIT share price is 1.46, making it a Sell technically.
-
EDIT stock price is 1.46 and Editas Medicine 200-day simple moving average is 3.23, creating a Sell signal.
EDIT Technical Analysis vs Fundamental Analysis
Sell
13
Editas Medicine (EDIT)
is a Sell
Is Editas Medicine a Buy or a Sell?
-
Editas Medicine stock is rated a SellThe current Editas Medicine [EDIT] share price is $1.46. The Score for EDIT is 13, which is 74% below its historic median score of 50, and infers higher risk than normal.
Editas Medicine Stock Info
Market Cap:
121.1M
Price in USD:
1.46
Share Volume:
1.7M
Editas Medicine 52-Week Range
52-Week High:
8.44
52-Week Low:
1.12
Sell
13
Editas Medicine (EDIT)
is a Sell
Editas Medicine Share Price Forecast
-
What is the Editas Medicine stock price today?The Editas Medicine stock price is 1.46 USD today.
-
Will EDIT stock go up or go down?Editas Medicine> share price is forecast to RISE/FALL based on technical indicators
-
Is Editas Medicine overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Editas Medicine is overvalued.
Is Editas Medicine Stock a Buy?
-
Editas Medicine share price is 1.46 while EDIT 8-day exponential moving average is 1.59, which is a Sell signal.
-
The stock price of EDIT is 1.46 while Editas Medicine 20-day EMA is 1.64, which makes it a Sell.
-
Editas Medicine 50-day exponential moving average is 1.68 while EDIT share price is 1.46, making it a Sell technically.
-
EDIT stock price is 1.46 and Editas Medicine 200-day simple moving average is 3.23, creating a Sell signal.
Fundamental Analysis of Editas Medicine
Is Editas Medicine a good investment?
-
Analysts estimate an earnings increase this quarter of $0.45 per share, a decrease next quarter of $0.02 per share, an increase this year of $1.12 per share, and an increase next year of $0.41 per share.
Technical Analysis of Editas Medicine
Should I short Editas Medicine stock?
-
EDIT Moving Average Covergence Divergence (MACD) indicator is -0, suggesting Editas Medicine is a Sell
-
Editas Medicine Relative Strength Index (RSI) is 45.59, which suggest Editas Medicine is oversold
-
The Bollinger Bands (25) for Editas Medicine is ( - ), which suggest Editas Medicine is a Buy
-
The Bollinger Bands (100) for Editas Medicine is ( - ), which suggest Editas Medicine is a Buy
* Editas Medicine stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.